Atritech is committed to responsibly establishing the WATCHMAN LAA Closure Technology as a Device Alternative to Warfarin Therapy, by demonstrating the safety and effectiveness of the technology through well designed and executed clinical trials and by providing the highest quality training and support to our customers.

To fulfill this commitment, Atritech has established the WATCHMAN University. WATCHMAN University houses our training program and other resources to support your efforts in establishing an effective LAA closure program in your institution. The formal training and educational activities have been developed in collaboration with experts in the field of LAA closure and by our Field Clinical Specialists who have been a part of more than 1200 implant procedures to date.